Patents Issued in February 6, 2007
  • Patent number: 7173081
    Abstract: A process is provided to produce an aqueous dispersion wherein the aqueous dispersion enhances the water and oil repellency of materials. The process comprises: 1) contacting at least one fluoroalkyl monomer, at least one water-dispersible polyester, water, and optionally an ethylenically unsaturated monomer to form a pre-emulsion; and 2) polymerizing the pre-emulsion in a polymerization zone in the presence of an initiator to produce the aqueous dispersion. In another embodiment, a process to produce an aqueous dispersion is provided. The process comprises: 1) contacting at least one fluoroalkyl monomer, at least one water-dispersible polyester, water, and optionally an ethylenically unsaturated monomer to form a pre-emulsion; 2) shearing the pre-emulsion to produce a mini-emulsion; and 3) polymerizing the miniemulsion in a polymerization zone to produce the aqueous dispersion.
    Type: Grant
    Filed: August 12, 2003
    Date of Patent: February 6, 2007
    Assignee: Hexion Specialty Chemicals, Inc.
    Inventors: James Foster Von Schmittou, Darrell Scott Nasser
  • Patent number: 7173082
    Abstract: The invention relates to an acrylic impact modifier having a core-shell structure that provides an acrylic impact modifier composition comprising (a) a rubber core containing an alkyl acrylate polymer comprising at least two layers having different cross-linking densities, and (b) a shell containing an alkyl methacrylate polymer; to a process for the preparation of the acrylic impact modifier; and to a poly(vinyl chloride) composition comprising it. The acrylic impact modifier imparting excellent impact resistance was invented by employing multi-stage polymerization and at the same time by controlling the swelling index of rubber particles by changing the degree of cross-linking from stage to stage. And the poly(vinyl chloride) comprising the impact modifier of the present invention has good weatherability as well as excellent impact strength.
    Type: Grant
    Filed: January 14, 2003
    Date of Patent: February 6, 2007
    Assignee: LG Chem, Ltd.
    Inventors: Jeong-Heon Ahn, Chang-Sun Han, Yong-Hun Lee, Seon-Hee Han, Kwang-Jin Lee, Hyung-Jun Son
  • Patent number: 7173083
    Abstract: An aqueous composition comprising components: (A) 50 to 99 wt. % of a vinyl polymer(s) having a gradient polymeric morphology; and (B) 1 to 50 wt. % of at least one polymer not having a gradient polymeric morphology, wherein components (A) and (B) add up to 100%.
    Type: Grant
    Filed: September 27, 2002
    Date of Patent: February 6, 2007
    Assignee: DSM IP Assets B.V.
    Inventors: Jurgen Scheerder, Tijs Nabuurs, Gerardus Cornelis Overbeek, Alfred Jean Paul Buckmann
  • Patent number: 7173084
    Abstract: Use of a polymer as a levelling agent or anti-cratering agent, said polymer comprising at least one fluorinated unit represented by formula 1, (Formula 1) wherein R?1 is a moiety represented by Cn?F2n+1?-(CH2?)m?-, ?Cn?F2n?-(CH2?)m?-, Cn?F2n+1?-(CII2?)m?-(OCII2?CIIR?5)p?-, ?Cn?F2n?-(CH2?m?-(OCH2?CHR?5)p?? Cn?F2n+1?-(CII2?)m?-X-, ACn?F2n?-(CII2?)m?-X-?Cn?F2n?-(CH2?)m?-(OCH2?CHR?5)p?-X or Cn?F2n+1?-(CII2?)m?-(OCII2?CIIR?5)p?-X-; wherein A=H, Cl, Br, I, a C1–12? alkyl or a OC1–12 ?alkyl, wherein 4?n?20,0?m˜?4 and 0?p?20, wherein X is a spacer moiety selected from the group consisting of esters, amides, sulphoamides, mercapto groups, poltyurethane groups and alkyl groups, wherein R?2, is H, a metal moiety, an (alkyl)ammonium moiety or an alkyl group, Cn?F2n+1?-(CII2?)m?-, ACn?F2n?-(CII2?)m?-, Cn?F2n+1?-(CII2?)m?-(OCII2?CIIR?5)p?-, ?Cn?F2n?-(CH2?)m?-(OCH2?CHR?5)p?? Cn?F2n+1?-(CH2?)m?-X-, ?Cn?F2n?-(CH2?)m?-X-, ACn?F2n?-(CH2?)m?-(OCH2?CHR?5)p?-X or Cn?F2n+1?-(CH2?)m?-(OCH2?CHR?5)p?-X-; wherein A=H, Cl, Br, I, C1–12?
    Type: Grant
    Filed: October 8, 2002
    Date of Patent: February 6, 2007
    Assignee: EFKA Additives B.V.
    Inventors: Frank Oliver Heinrich Pirrung, Elizabeth Maaike Loen, Lothar Alexander Engelbrecht, Arend Noordam
  • Patent number: 7173085
    Abstract: This invention relates to aqueous emulsions comprising a water-dispersible copolymer which is non-dispersible in aqueous solutions containing 0.5% or more of an inorganic salt, comprising acidic ethylenically unsaturated monomers and ethylenically unsaturated monomers. The acidic ethylenically unsaturated monomers and the ethylenically unsaturated monomers are defined herein. The present invention also pertains to emulsion polymerization methods for making the aqueous emulsions with or without a surfactant.
    Type: Grant
    Filed: January 21, 2004
    Date of Patent: February 6, 2007
    Assignee: Celanese International Corporation
    Inventor: Michael W. Eknoian
  • Patent number: 7173086
    Abstract: The invention relates to absorptive, crosslinked polymers which are based on partly neutralized, monoethylenically unsaturated monomers carrying acid groups wherein the absorptive crosslinked polymer may be coated with a thermoplastic polymer, and have improved properties, in particular in respect of their capacity for transportation of liquids in the swollen state, and which has a high gel bed permeability and high centrifuge retention capacity.
    Type: Grant
    Filed: October 31, 2003
    Date of Patent: February 6, 2007
    Assignee: Stockhausen, Inc.
    Inventors: Scott J. Smith, Stan McIntosh, Heinz Bremus, Frank Loeker
  • Patent number: 7173087
    Abstract: A hydrogenated nitrite rubber composition for providing a cross-linked product having a 20% modulus of 10 MPa or more and a thermal conductivity of 0.4 W/m·K or more at 25° C. The hydrogenated nitrile rubber composition includes 100 parts by weight of hydrogenated nitrile rubber having a bound acrylonitrile content of 40% or more, a polymer Mooney viscosity ML1+4 (100° C.) of 75 or less (median) as determined according to JIS K-6395, an iodine value of 23 or less (median), and at least 110 parts by weight in sum total of carbon black as a filler and other gas shielding filler. The hydrogenated nitrile rubber composition can effectively be used as a molding material for sliding applications or for a static sealing members for highly permeable gases. The hydrogenated nitrile rubber composition has a distinguishing carbon dioxide gas shieldability, heat resistance, and wear characteristics.
    Type: Grant
    Filed: August 19, 2003
    Date of Patent: February 6, 2007
    Assignee: NOK Corporation
    Inventors: Hideyuki Tokumitsu, Takuya Yamanaka
  • Patent number: 7173088
    Abstract: A golf ball comprising a core; an intermediate layer having a flexural modulus of between about 65,000 psi and about 120,000 psi and being formed from a polymer blend comprising a first material selected from the group consisting of thermoset polyurethanes, thermoset polyetheresters, and thermoset polyetheramides and a second material comprising a grafted-metallocene polymer; and a cover layer comprising a castable reactive liquid thermoset polyurea.
    Type: Grant
    Filed: September 21, 2005
    Date of Patent: February 6, 2007
    Assignee: Acushnet Company
    Inventors: Herbert C Boehm, William E Morgan, Jeffrey L Dalton, Douglas E Jones, Christopher Cavallaro, Murali Rajagopalan
  • Patent number: 7173089
    Abstract: This invention is directed to a processing approach for the rapid and efficient in-situ polymerization of specially prepared precursor mixtures to achieve near-net-shape production of objects/articles with exact dimensions. The process relies on the use of polymerizable compositions comprised of a mixture of a dead polymer, a reactive plasticizer and, optionally, an initiator, which compositions are semi-solid-like prior to curing and induce low shrinkage upon curing as a result of their partially polymerized nature prior to processing. The partially polymerized nature of the precursor mixtures also allows extremely impact-resistant objects/articles to be fabricated. Other desirable engineering property attributes can similarly be achieved via the judicious blending of starting ingredients in formulating the polymerizable (curable) mixtures.
    Type: Grant
    Filed: February 25, 2002
    Date of Patent: February 6, 2007
    Assignee: ZMS, LLC.
    Inventors: David S. Soane, Michael R. Houston, Toshiaki Hino
  • Patent number: 7173090
    Abstract: A polyphenylene sulfide resin composition including a polyphenylene sulfide resin having a specific amount of oligomers and a specific amount of a functional group, an amorphous thermoplastic resin having a glass transition temperature (Tg) of 120° C. or higher, and an additive having a specific amount of a functional group. The moldings obtained from this polyphenylene sulfide resin composition have a good toughness (impact strength) and weld strength. The use of this polyphenylene sulfide resin composition as a material for secondary battery cases makes it possible to maintain the initial electrolytic performance over a long period of time.
    Type: Grant
    Filed: October 25, 2001
    Date of Patent: February 6, 2007
    Assignee: Asahi Kasei Chemicals Corporation
    Inventors: Yoshikuni Akiyama, Minoru Sakata, Kuniaki Minonishi
  • Patent number: 7173091
    Abstract: The invention relates to a polymer blend and a process for its preparation. The polymer blend contains A) a polymer of an olefin and an unsaturated carboxylic acid, wherein the amount of acid groups is 0.5–15 molar %, and B) a polyether block polymer made up of a polyether block and a polyamide or polyester block, the acid groups in polymer A and the polyether blocks in polymer B having at least partly coordinated alkali ions, and an alkali metal being present in an amount of approx. 0.02–3 millimols/gram of the polymer blend. The blend according to the invention has a good electrical conductivity and excellent mechanical properties.
    Type: Grant
    Filed: June 25, 2002
    Date of Patent: February 6, 2007
    Assignee: Ionphase Oy
    Inventor: Jyri Nieminen
  • Patent number: 7173092
    Abstract: A method is disclosed for preparing an elastomeric base composition comprising: (I) mixing (A) a fluorocarbon elastomer with (B) a compatibilizer, (C) an optional catalyst, (II) mixing the product of step (I) with (D) a silicone base comprising a curable organopolysiloxane, (E), an optional crosslinking agent, (F) a cure agent in an amount sufficient to cure said organopolysiloxane; and (III) dynamically vulcanizing the organopolysiloxane, wherein the weight ratio of fluorocarbon elastomer (A) to silicone base (B) in the elastomeric base composition ranges from 95:5 to 30:70. The cured rubber compositions obtained from the elastomeric base compositions herein have good fuel resistance properties.
    Type: Grant
    Filed: June 6, 2003
    Date of Patent: February 6, 2007
    Assignee: Dow Corning Corporation
    Inventors: Gerald Gornowicz, Igor Chorvath, Lauren Tonge, Yung Kim, David Romenesko, Kermit Kwan, Stephen Warren
  • Patent number: 7173093
    Abstract: The invention relates to a novel, impact-resistant polymer based on PMMA.
    Type: Grant
    Filed: January 15, 2003
    Date of Patent: February 6, 2007
    Assignee: Roehm GmbH & Co. KG
    Inventors: Klaus Kabs, Oliver Mueck
  • Patent number: 7173094
    Abstract: Moldings of fluoro rubbers produced by crosslinking a tetrafluoroethylene/propylene copolymer or a tetrafluoroethylene/propylene/vinylidene fluoride copolymer, which have metal contents of 1.5% by mass or below in terms of metal elements and are suitable for use applications necessitating clean environment, for example, manufacturing or carrier equipment for semiconductors, manufacturing equipment, carriers, or storage containers for food, or medical supplies.
    Type: Grant
    Filed: September 20, 2002
    Date of Patent: February 6, 2007
    Assignees: Nichias Corporation, Asahi Glass Co., Ltd.
    Inventors: Kazuki Morimoto, Naoya Kuzawa, Hitoshi Ogura, Takumi Arisawa, Takeshi Kuboyama, Kinro Hashimoto, Hitoshi Yamada, Masayuki Saito, Tetsuya Miwa
  • Patent number: 7173095
    Abstract: The invention relates to a polymerization process wherein at least one peroxide, with a half life in between 1 hour and 0.001 hour at the polymerization temperature at the moment of dosing, is dosed to the reaction mixture at the polymerization temperature and wherein at least during part of the period in which the peroxide is dosed i) the cooling means of the reactor are kept at essentially maximum cooling capacity and ii) the amount of initiator that is dosed is actively controlled such that the desired polymerization temperature is achieved and maintained within 0.3° C. of said polymerization temperature.
    Type: Grant
    Filed: June 15, 2004
    Date of Patent: February 6, 2007
    Assignee: Akzo Nobel N. V.
    Inventors: Lambertus Meulenbrugge, Andreas Petrus Van Swieten, Koen Antoon Kornelis Vanduffel, Hans Westmijze
  • Patent number: 7173096
    Abstract: Chemically crosslinked polycyclooctene having excellent shape recovery properties and a method for its synthesis via ring-opening methathesis polymerization of cyclooctene using the dihydroimidazolylidene-modified Grubbs catalyst are disclosed. The polycyclooctene products, following curing with dicumyl peroxide can be shaped, the shape memorized, a new shape imparted with the original shape being recoverable by suitable temperature adjustment. The dependence of shape memory characteristics on degree of crosslinking was established. In addition to polycyclooctene, blends thereof with other materials such as SBR, EVA, polyurethane rubbers, and inorganic fillers can be utilized to provide chemically crosslinked products having excellent and tailored shape memory properties.
    Type: Grant
    Filed: October 10, 2003
    Date of Patent: February 6, 2007
    Assignee: University of Connecticut
    Inventors: Patrick T. Mather, Changdeng Liu, Seung B. Chun, E. Bryan Coughlin
  • Patent number: 7173097
    Abstract: A composition curable by a metathesis reaction upon mixing its components and comprising an olefin-containing substrate, a metathesis catalyst, and a reaction control agent for slowing the progress of the metathesis reaction. The metathesis catalyst is a ruthenium or osmium carbene complex catalyst having high activity and good air stability. In one embodiment, the catalyst is free of phosphine ligands. The reaction control agent is an organic compound that contains carbon-carbon double and/or triple bonds and one or more Group 14 atoms and is present in an amount effective to slow the progress of the metathesis reaction. In one embodiment, the olefin-containing substrate may comprise one or more oligomers or polymers having a >20 wt. % linear siloxane (Si—O—Si) backbone tethered and/or end-capped with functional olefin groups, such as cycloalkenyl groups.
    Type: Grant
    Filed: July 15, 2004
    Date of Patent: February 6, 2007
    Assignee: Kerr Corporation
    Inventor: Christos Angeletakis
  • Patent number: 7173098
    Abstract: The present invention has for its object to provide a method of producing fluoropolymers with high productivity under comparatively low temperature and low pressure conditions which are conducive to reduced cost of commercial-scale production equipment. The present invention is directed to a method of producing a fluoropolymer which comprises polymerizing a radical polymerizable monomer in a defined reaction-field, said radical polymerizable monomer comprising a fluorine-containing ethylenic monomer and said defined reaction-field being in supercriticality-expression state with a monomer density [?m]-monomer critical density [?0] ratio of [?m/?0] not less than 1.1.
    Type: Grant
    Filed: November 1, 2002
    Date of Patent: February 6, 2007
    Assignee: Daikin Industries, Ltd.
    Inventors: Mitsuo Tsukamoto, Kenji Otoi, Hideki Nakaya, Yoshiyuki Hiraga, Tomohisa Noda
  • Patent number: 7173099
    Abstract: The propylene polymer of the present invention satisfies (1) a 25° C. hexane soluble content (H25) of 0–80 wt %; and (2) either no melting temperature (Tm) measurable by differential scanning calorimetry (DSC), or a melting temperature (Tm) satisfying, if measurable by DSC, the following relationship: ?H?3×(Tm?120) wherein ?H is a melting endotherm (J/g). The propylene homopolymer of the present invention satisfies (1) a meso pentad fraction (mmmm) of 30–60 mol %; (2) a racemic pentad fraction (rrrr) satisfying the following relationship: [rrrr/(1?mmmm)]?0.1; (3) a fraction (W25) eluted at a temperatures up to 25° C. by temperature-programmed chromatography, of from 20–100 wt %; and, (4) a pentad fraction (rmrm) of more than 2.5 mol %. The propylene copolymer of the present invention satisfies (1) a stereoregularity index (P) of 55–90 mol % as determined by 13C-NMR measurement; and (2) a fraction (W25) eluted at a temperatures up to 25° C. by temperature-programmed chromatography, of from 20–100 wt %.
    Type: Grant
    Filed: October 5, 2000
    Date of Patent: February 6, 2007
    Assignee: Idemitsu Kosan Co., Ltd.
    Inventor: Yutaka Minami
  • Patent number: 7173100
    Abstract: The present invention relates to a receiving-layer-forming polyester resin for use in a thermal-transfer image-receiving sheet, comprising: not less than 70 mol % of isophthalic acid and not more than 30 mol % of terephthalic acid as acid components; and not less than 30 mol % of diols having an alicyclic structure and not more than 30 mol % of ethylene glycol as diol components, and a thermal-transfer image-receiving sheet with a receiving layer formed on at least one of surfaces of the substrate sheet, in which the receiving layer is formed by such a receiving-layer-forming polyester resin.
    Type: Grant
    Filed: March 30, 2005
    Date of Patent: February 6, 2007
    Assignee: Dai Nippon Printing Co., Ltd.
    Inventors: Naoyuki Mitsuyasu, Masayasu Yamazaki, Taro Suzuki, Minoru Takahashi, Hirotoshi Kizumoto
  • Patent number: 7173101
    Abstract: An inventive blue colorant comprising a chromophore having at least one hydroxy group-terminated polyester chain attached, through a suitable alkylamino linking group (or groups), to the 1-position, the 4-position, or both, of an anthraquinone backbone and having at least one hindering group in a secondary position in relation to said amino linking group is provided. Such colorants exhibit excellent amine/base stability and thermal stability, effective colorations, excellent low extraction rates, high lightfastness levels, particularly when incorporated within certain media and/or on the surface of certain polyurethane substrates, and, most importantly excellent stability in the presence of excess of diisocyanates.
    Type: Grant
    Filed: June 14, 2003
    Date of Patent: February 6, 2007
    Assignee: Milliken & Company
    Inventor: Jusong Xia
  • Patent number: 7173102
    Abstract: Facially amphiphilic polymers and articles made therefrom having biocidal surfaces are disclosed. The polymers can inhibit the growth of microorganisms in contact with the surface or in areas adjacent to said biocidal surface. There is also disclosed a method to identify and optimize the facial amphiphilicity of polyamide, polyester, polyurea, polyurethane, polycarbonate and polyphenylene polymers. Utility as a contact disinfectant is disclosed.
    Type: Grant
    Filed: March 7, 2002
    Date of Patent: February 6, 2007
    Assignee: The Trustees of the University of Pennsylvania
    Inventors: William F. DeGrado, Gregory N. Tew, Michael L. Klein, Dahui Liu, Jing Yuan
  • Patent number: 7173103
    Abstract: A process for preparing high molecular weight polymers or copolymers by Suzuki coupling. The catalyst used in the process comprises a source of palladium and a source of a phosphine characterized in that at least one substituent on the phosphine is an ortho substituted aryl group. The process is suitable for the preparation of polymers for use in electronic and optoelectronic applications.
    Type: Grant
    Filed: October 21, 2002
    Date of Patent: February 6, 2007
    Assignee: Cambridge Display Technology Limited
    Inventors: Carl Towns, Paul Wallace, Ian Allen, Thomas Pounds, Lorraine Murtagh
  • Patent number: 7173104
    Abstract: The invention relates to products, especially moulding materials of polymers containing triazine segments and consisting of mixtures of meltable 4–18 ring oligotriazine ethers which are soluble in highly polar solvents, and in which the triazine rings are predominantly linked by alkylene diamino groups. Said moulding materials can contain up to 50 mass % of other reactive polymers such as ethylene copolymers, maleic acid anhydride copolymers, modified maleic acid anhydride copolymers, poly(meth)acrylates, polyamides, polyester and/or polyurethanes, up to 75 mass % of filling materials and/or reinforcing fibres, and up to 2 mass % of stabilisers, UV absorbers and/or auxiliary agents. The moulding materials of polymers containing triazine segments can be processed by means of conventional fusion methods and can be used as hot-melt adhesives and for producing plates, tubes, profiles, injection moulded parts, fibres, coatings and foamed material.
    Type: Grant
    Filed: November 19, 2002
    Date of Patent: February 6, 2007
    Assignee: AMI - Agrolinz Melamine International GmbH
    Inventors: Manfred Rätzsch, Hartmut Bucka, René Dicke, Martin Burger, Steffen Pfeiffer, Christian Fürst
  • Patent number: 7173105
    Abstract: The present invention relates to polynucleotides corresponding to the luxR gene and which encode a LuxR transcriptional activator, methods of producing L-amino acids, and methods of screening for polynucleotides which encode proteins having LuxR transcriptional activation activity.
    Type: Grant
    Filed: December 27, 2004
    Date of Patent: February 6, 2007
    Assignee: Degussa AG
    Inventors: Bettina Moeckel, Caroline Kreutzer, Brigitte Bathe
  • Patent number: 7173106
    Abstract: A potent and highly specific insecticidal toxin comprising 45 residues and three intramolecular disulfide bonds, as well as a method for selecting potent inhibitors of insect calcium channels.
    Type: Grant
    Filed: May 12, 2003
    Date of Patent: February 6, 2007
    Assignee: University of Connecticut
    Inventors: Glenn F. King, Xiu-hong Wang
  • Patent number: 7173107
    Abstract: The stereospecific synthesis of a glycopeptide using a triply orthogonal protection scheme is described, in particular, the synthesis of N-acetylglucosaminyl-?-[1,4]-N-acetylmuramylmonopeptide and derivatives thereof. The glycopeptide is useful for the preparation of GMDP and related compounds having a glucosaminyl-?-[1,4]-N-acetylmuramic acid disaccharide core.
    Type: Grant
    Filed: April 18, 2001
    Date of Patent: February 6, 2007
    Assignee: Eli Lilly and Company
    Inventors: Larry Chris Blaszczak, Elizabeth Anne Dingess-Hammond, William Joseph Hornback, Michael Scott VanNieuwenhze
  • Patent number: 7173108
    Abstract: The invention provides methods for identifying peptide epitopes that activate CD4+ T cells involved in the pathogenesis of diseases, e.g., autoimmune diseases, susceptibility to which is determined by expression of particular class II MHC genes. The invention includes peptides derived from the IA-2 polypeptide by such a method, altered peptide ligands, and methods of therapy involving the use of altered peptide ligands.
    Type: Grant
    Filed: March 3, 2003
    Date of Patent: February 6, 2007
    Assignees: MGI Pharma Biologics, Inc., King's College London
    Inventors: Mark Peakman, Roman M. Chicz
  • Patent number: 7173109
    Abstract: The present invention relates to a fluorescently labeled growth hormone secretagogue which can be used for the identification of compounds capable of binding to growth hormone secretagogue receptors, in particular by high throughput screening.
    Type: Grant
    Filed: October 14, 2004
    Date of Patent: February 6, 2007
    Assignee: Hoffmann-La Roche Inc.
    Inventors: Thilo Enderle, Martin Graf, Cornelia Hertel, Sannah Jensen Zoffmann, Eric Argirios Kitas
  • Patent number: 7173110
    Abstract: Disclosed herein are isolated, purified peptides, biologically active fragments and analogs of the peptides having anti-tumor activity in mammals, pharmaceutical formulations comprising the peptides, fragments and analogs and methods of treating mammals suffering from tumors using such materials.
    Type: Grant
    Filed: October 31, 2005
    Date of Patent: February 6, 2007
    Assignee: New York University
    Inventor: Martin J. Rosenberg
  • Patent number: 7173111
    Abstract: An isolated WT1 interacting protein having the amino acid sequence as set forth in SEQ ID NO: 2, or an isolated protein that has an amino acid sequence in which one or a plurality of amino acids have been substituted, deleted, inserted, and/or added is functionally equivalent to the protein having the amino acid sequence as set forth in SEQ ID NO: 2; and comprises the amino acid sequence from Glu at position 449 to Met at position 541 in SEQ ID NO: 2.
    Type: Grant
    Filed: January 24, 2001
    Date of Patent: February 6, 2007
    Inventors: Haruo Sugiyama, Eui Ho Kim
  • Patent number: 7173112
    Abstract: The present invention intends to provide a novel monoclonal antibody having a binding specificity to GALP or its derivative, which is useful in developing therapeutic agents, preventive agents or diagnostic agent for diseases associated with GALP or its derivative, and a method of quantifying GALP using the antibody. More specifically, the present invention provides an antibody specifically reacting with a partial peptide in the C-terminal region of a polypeptide having the amino acid sequence represented by SEQ ID NO: 1, SEQ ID NO: 2 or SEQ ID NO: 3, or its derivative, and a method of quantifying GALP or its derivative.
    Type: Grant
    Filed: September 25, 2002
    Date of Patent: February 6, 2007
    Assignee: Takeda Pharmaceutical Company Limited
    Inventors: Hirokazu Matsumoto, Yasuko Horikoshi, Chieko Kitada, Tetsuya Ohtaki
  • Patent number: 7173113
    Abstract: This invention provides VEGF-FSH compounds having increased serum half-lives relative to either native VEGF or FSH, in which both VEGF and FSH are biologically active. This invention also provides related compositions and methods for increasing fertility, egg production and spermatogenesis in a subject, as well as methods for increasing vascularization in a tissue, particularly in ovarian tissue.
    Type: Grant
    Filed: April 9, 2002
    Date of Patent: February 6, 2007
    Assignee: The Trustees of Columbia University in the City of New York
    Inventors: Joyce Lustbader, Leslie Lobel
  • Patent number: 7173114
    Abstract: A lightfast colorant and a lightfast ink composition including the lightfast colorant utilize a lightfast colorant that is derived by covalently binding a cinnamate derivative and a conventional colorant. The lightfast colorant improves storage stability as well as lightfastness when added to an ink composition.
    Type: Grant
    Filed: February 6, 2004
    Date of Patent: February 6, 2007
    Assignee: Samsung Electronics Co., Ltd.
    Inventors: Kyung-hoon Lee, Seung-min Ryu, Yeon-Kyoung Jung
  • Patent number: 7173115
    Abstract: The present invention is directed to novel polypeptides having sequence similarity to Stra6, a murine retinoic acid responsive protein, and to nucleic acid molecules encoding those polypeptides. Also provided herein are vectors and host cells comprising those nucleic acid sequences, chimeric polypeptide molecules comprising the polypeptides of the present invention fused to heterologous polypeptide sequences, antibodies which bind to the polypeptides of the present invention and to methods for producing the polypeptides of the present invention.
    Type: Grant
    Filed: January 11, 2001
    Date of Patent: February 6, 2007
    Assignee: Genentech, Inc.
    Inventors: Diane Pennica, Victoria Smith, William I. Wood
  • Patent number: 7173116
    Abstract: A nucleic acid formulation for use in gene delivery comprising a nucleic acid and an anionic polymer is disclosed. Examples of the anionic polymer includes aniionic amino acid polymer or poly-amino acid (such as poly-L-glutamic acid, poly-D-glutamic acid, poly-L-aspartic acid, poly-D-aspartic acid), poly-acrylic acid, polynucleotides, poly galacturonic acid, and poly vinyl sulfate.
    Type: Grant
    Filed: September 3, 2002
    Date of Patent: February 6, 2007
    Assignee: Genetronics Biomedical Corporation
    Inventors: Jason Fewell, Fiona MacLaughlin, Louis C. Smith, Francois Nicol, Alain Rolland
  • Patent number: 7173117
    Abstract: The present invention relates to codon optimised polynucleotides which are efficiently expressed in mammalian cells and encode insect proteins from Dermaphagoids dust mite. In particular, the optimised codon polynucleotides encode a protein from Dermaphagoides pteronyssinus, such as DerP1 or proDerP1. The present invention also provides methods of preparing pharmaceutical compositions comprising the expression of the codon optimised polynucleotides, and vectors and transformed host cells comprising them.
    Type: Grant
    Filed: June 7, 2001
    Date of Patent: February 6, 2007
    Assignee: GlaxoSmithKline Biologicals S.A.
    Inventors: Alex Bollen, Paul Jacobs, Alain Jacquet, Marc Georges Francis Massaer
  • Patent number: 7173118
    Abstract: The invention relates generally to genes that encode proteins that inhibit axonal growth. The invention relates specifically to genes encoding NgR protein homologs in humans and mice. The invention also includes compositions and methods for modulating the expression and activity of Nogo and the NgR proteins. Specifically, the invention includes peptides, proteins and antibodies that block Nogo-mediated inhibition of axonal extension. The compositions and methods of the invention are useful in the treatment of cranial or cerebral trauma, spinal cord injury, stroke or a demyelinating disease.
    Type: Grant
    Filed: December 12, 2003
    Date of Patent: February 6, 2007
    Assignees: Biogen Idec MA Inc., Yale University
    Inventors: Stephen M. Strittmatter, Richard L. Cate, Dinah W. Y. Sah
  • Patent number: 7173119
    Abstract: Novel nucleic acids associated with Type 1 diabetes. Also provided are polypeptides encoded by the nucleic acids associated with T1D. The invention also provides methods for facilitating the diagnosis or pre-diagnosis of T1D through the use of such nucleic acids and polypeptides. This invention further provides compositions for the treatment of Type 1 diabetes.
    Type: Grant
    Filed: March 25, 2005
    Date of Patent: February 6, 2007
    Assignee: Medical College of Georgia Research Institute
    Inventors: Jin-Xiong She, Cong-Yi Wang
  • Patent number: 7173120
    Abstract: The invention relates to regulatory sequences that regulate gene expression in the mesocarp and/or senescent leaves of certain plants. In certain embodiments, the invention is directed to abundant and selective expression of type 3 metallothionein-like genes in the mesocarp of a variety of plants including members of the Palme family. The invention also relates to methods of generating transgenic plants and plant tissues that comprise a nucleic acid of the invention. The invention further provides products derived from transgenic plants, plant materials or plant cells of the invention. Particular applications in oil palms are discussed. The invention further relates to nucleic acid constructs of the invention in cells of organisms other than plants.
    Type: Grant
    Filed: May 10, 2002
    Date of Patent: February 6, 2007
    Assignee: Malaysian Palm Oil Board
    Inventors: Siti Nor Akmar Abdullah, Zubaidah Ramli
  • Patent number: 7173121
    Abstract: The present invention is directed to promoter sequences and promoter control elements, polynucleotide constructs comprising the promoters and control elements, and methods of identifying the promoters, control elements, or fragments thereof. The invention further relates to the use of the present promoters or promoter control elements to modulate transcript levels.
    Type: Grant
    Filed: September 23, 2004
    Date of Patent: February 6, 2007
    Assignee: Ceres, Inc
    Inventor: Yiwen Fang
  • Patent number: 7173122
    Abstract: The invention provides antisense DNA oligonucleotides which are effective in inhibiting the expression of a wild type COL1A1 gene.
    Type: Grant
    Filed: December 12, 2000
    Date of Patent: February 6, 2007
    Inventor: Rajinder Beri
  • Patent number: 7173123
    Abstract: Methods for detecting chloral hydrate in dichloroacetic acid are described.
    Type: Grant
    Filed: October 6, 2003
    Date of Patent: February 6, 2007
    Assignee: Isis Pharmaceuticals, Inc.
    Inventors: Patrick Wheeler, Daniel C. Capaldi
  • Patent number: 7173124
    Abstract: The present invention provides a method of isolating nucleic acid from a sample, said method comprising contacting said sample with a detergent and a solid support, whereby soluble nucleic acid in said sample is bound to the support, and separating said support with bound nucleic acid from the sample. Where the method of the invention is used to isolate DNA, it may conveniently be couple with a further step to isolate RNA from the same sample.
    Type: Grant
    Filed: September 23, 2005
    Date of Patent: February 6, 2007
    Assignee: Invitrogen Dynal AS
    Inventors: Arne Helge Deggerdal, Frank Larsen
  • Patent number: 7173125
    Abstract: Hydrazino, oxyamino and carbonyl-based monomers and methods for incorporation into oligonucleotides during enzymatic synthesis are provided. Modified oligonucleotides are provided that incorporate the monomers provided herein. Immobilized oligonucleotides and oligonucleotide conjugates that contain covalent hydrazone or oxime linkages are provided. Methods for preparation of surface bound oligonucleotides are provided. Methods for the preparation of oligonucleotide conjugates are also provided.
    Type: Grant
    Filed: November 24, 2003
    Date of Patent: February 6, 2007
    Inventors: David A. Schwartz, Richard I. Hogrefe
  • Patent number: 7173126
    Abstract: Cefdinir crystalline salts of formula (I), in which n ranges from 1 to 3, the preparation and use thereof for the preparation and purification of cefdinir are herein disclosed. The salts of formula (I) can be obtained from cefdinir intermediates or crude cefdinir by treatment with phosphoric acid.
    Type: Grant
    Filed: December 1, 2003
    Date of Patent: February 6, 2007
    Assignee: Antibioticos S.p.A.
    Inventors: Giovanni Pozzi, Patricio Martin Gomez, Marco Alpegiani, Walter Cabri
  • Patent number: 7173127
    Abstract: This invention relates to a continuous and efficient method for the manufacture of highly pure caprolactam suitable for the polycondensation of Polyamide 6 (polycaprolactam) from polyamide waste. In particular the invention relates to a method for the manufacture of caprolactam from waste containing polyamides, including the steps a) depolymerisation of the waste containing polyamides, whereby a caprolactam raw material and a flow containing secondary constituents or additives is obtained, b) at least one distillation of the caprolactam raw material, and c) at least one crystallisation of the caprolactam material obtained in step b), by which means caprolactam is obtained, whereby at least part of the caprolactam obtained in step c) with a permanganate number of<10000 sec. and a UV transmission of<85% is added to the waste containing polyamides before and/or during the depolymerisation.
    Type: Grant
    Filed: June 9, 2003
    Date of Patent: February 6, 2007
    Assignee: Zimmer Aktiengesellschaft
    Inventors: Claus Born, Rudolf K{hacek over (a)}mpf, Joachim Seelig, Reinhard Wolf
  • Patent number: 7173128
    Abstract: The present invention relates to novel ultraviolet light absorbers of the benzoxazinone, oxanilide, benzylidene malonate, quinazoline and benzotriazole classes. The invention also relates to polymer and photographic compositions stabilized against the deleterious effects of light induced degradation which comprise the novel ultraviolet light absorbers.
    Type: Grant
    Filed: August 5, 2002
    Date of Patent: February 6, 2007
    Assignee: Ciba Specialty Chemicals Corporation
    Inventors: Ramanathan Ravichandran, Stephen Daniel Pastor, Deborah Judd, Joseph Edmund Babiarz, Andrew Brian Naughton, Mervin Gale Wood, Anthony David Debellis, Rong Xiong, Robert Edward Detlefsen, Joseph Suhadolnik
  • Patent number: 7173129
    Abstract: The invention relates to compounds, pharmaceutical compositions and methods of using compounds of the general formula or its pharmaceutically acceptable salt or ester, wherein the substituents are defined in the application.
    Type: Grant
    Filed: June 7, 2004
    Date of Patent: February 6, 2007
    Assignee: Athero Genics, Inc.
    Inventors: Kimberly J. Worsencroft, Liming Ni, Zhihong Ye, Charles Q. Meng, M. David Weingarten, Jacob E. Simpson, James A. Sikorski
  • Patent number: 7173130
    Abstract: Methods and compositions are provided for detecting changes in membrane potential in membranes biological systems. In one aspect, the method comprises; a) providing a living cell with a first reagent comprising a charged hydrophobic molecule which is typically a fluorescence resonance energy transfer (FRET) acceptor or donor, or is a quencher and is capable of redistributing within the membrane of a biological membrane in response to changes in the potential across the membrane; b) providing the cell with a second reagent that can label the first face or the second face of a biological membrane within the cell; c) detecting light emission from the first reagent or the second reagent. One aspect of this method involves monitoring membrane potential changes in subcellular organelle membranes in a living cells. Another aspect of the invention is the use of certain embodiments of the method for the screening of test chemicals for activity to modulate the activity of a target ion channel.
    Type: Grant
    Filed: September 28, 2001
    Date of Patent: February 6, 2007
    Assignee: The Regents of the University of California
    Inventors: Roger Y. Tsien, Jesus E. Gonzalez, III